Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Development of CIRC Technologies

The Cleveland Clinic · NCT05654272

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
1000
US sites recruiting
1
Study start
September 9, 2022
Record last updated
May 8, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Cardiovascular disease is the leading cause of death worldwide. Advanced cardiovascular imaging using Magnetic Resonance Imaging (MRI) has proven to be effective in providing gold standard myocardial tissue characterization. Moreover, the intrinsic advantage of MRI's lack of exposure to ionizing radiation is particularly beneficial. At the same time, blood work can be very useful in early detection of certain cardiomyopathy, such as amyloid. However, there is a lack of agreement of on which markers are the most sensitive. This multi-study will allow us the unique opportunity to form a more comprehensive understanding for various cardiovascular diseases.

Our team has developed novel cardiac MRI techniques that leverages endogenous tissue properties to reveal a milieu of deep tissue phenotypes including myocardial inflammation, fibrosis, metabolism, and microstructural defects. Among these phenotypes, myocardial microstructure has proven to be most sensitive to early myocardial tissue damage and is predictive of myocardial regeneration. In this study, the investigators aim to further study the importance of cardiac microstructure revealed by MRI in patient and healthy population and compare this novel technology with conventional clinical biomarkers.

Being studied: MRI

Conditions: Cardiovascular Diseases; Heart Failure; Ischemic Heart Disease; Non-ischemic Cardiomyopathy; Valvular Heart Disease; Metabolic Cardiomyopathy; Congenital Heart Disease; Aortic Diseases; Atrial Fibrillation; Ventricular Fibrillation

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Age ≥ 18 years of age
  • Provision of written informed consent
  • If not healthy volunteer, must be diagnosed with cardiovascular disease

Exclusion Criteria

  • Vulnerable populations will be excluded from this study including Prisoners
  • Other contraindications to CMR imaging to be determined by standard MRI protocols
  • Decisionally impaired (e.g., dementia or cognitive disability)

Recruiting US locations

  • Cardiovascular Innovation Research Center

    Cleveland, OH 44195

    Site contact: Lily Chen · 216-445-8561 · chens7@ccf.org

Study contacts (from the official record)

  • CIRC Program Coordinator · 216 636-5373 · circ@ccf.org
  • CIRC Study Coordinator · chens7@ccf.org
Development of CIRC Technologies (NCT05654272) | Bored Studies